Abstract
Objective: The aim of this study was to examine the effect of conjugated equine estrogens alone (ET), conjugated equine estrogens + medroxyprogesterone (EPT), calcitriol alone, calcitriol + EPT/ET, or placebo on serum lipid profile and analyze the interaction with estrogen receptor-α gene single nucleotide polymorphisms (ESR-α SNPs) on the response to therapy. Methods: A total of 489 postmenopausal women older than 65 years were enrolled into a 3-year double-blind, placebo-controlled clinical trial. Results: In both intent-to-treat and complier (>80% adherent) analysis, there was a significant increase in serum high-density lipoproteins and a significant decrease in serum low-density lipoproteins (LDLs) and the LDL/high-density lipoprotein ratio in all hormone treatment groups compared with placebo (P <0.05). However, serum triglycerides and very low-density lipoproteins increased in the EPT and ET + calcitriol groups versus placebo (P <0.05). ESR-α SNPs PvuII and XbaI seemed to have a significant effect on the response to treatment. Genotypes containing the p allele showed a significantly greater decrease in serum cholesterol and very low-density lipoprotein than those having the P allele in the ET + calcitriol group (P <0.05), and those with the x allele had a significantly greater decrease in serum cholesterol in the hormone therapy + calcitriol group at the end of 3 years versus the X allele, and a greater decrease in serum LDL in alleles x versus the X in the ET + calcitriol group (P <0.05). Conclusions: ET with or without progesterone had a favorable effect on lipid profile in postmenopausal older women, and this was dependent on estrogen receptor SNPs-PvuII and XbaI. However, this interaction with ESR-α SNPs needs to be confirmed in larger studies.
| Original language | English |
|---|---|
| Pages (from-to) | 1101-1112 |
| Number of pages | 12 |
| Journal | Menopause |
| Volume | 18 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2011 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Obstetrics and Gynecology
Cite this
Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women : Association with estrogen receptor-α genotypes. / Sai, Adarsh J.; Gallagher, John Christopher G.; Fang, Xiang.
In: Menopause, Vol. 18, No. 10, 10.2011, p. 1101-1112.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women
T2 - Association with estrogen receptor-α genotypes
AU - Sai, Adarsh J.
AU - Gallagher, John Christopher G.
AU - Fang, Xiang
PY - 2011/10
Y1 - 2011/10
N2 - Objective: The aim of this study was to examine the effect of conjugated equine estrogens alone (ET), conjugated equine estrogens + medroxyprogesterone (EPT), calcitriol alone, calcitriol + EPT/ET, or placebo on serum lipid profile and analyze the interaction with estrogen receptor-α gene single nucleotide polymorphisms (ESR-α SNPs) on the response to therapy. Methods: A total of 489 postmenopausal women older than 65 years were enrolled into a 3-year double-blind, placebo-controlled clinical trial. Results: In both intent-to-treat and complier (>80% adherent) analysis, there was a significant increase in serum high-density lipoproteins and a significant decrease in serum low-density lipoproteins (LDLs) and the LDL/high-density lipoprotein ratio in all hormone treatment groups compared with placebo (P <0.05). However, serum triglycerides and very low-density lipoproteins increased in the EPT and ET + calcitriol groups versus placebo (P <0.05). ESR-α SNPs PvuII and XbaI seemed to have a significant effect on the response to treatment. Genotypes containing the p allele showed a significantly greater decrease in serum cholesterol and very low-density lipoprotein than those having the P allele in the ET + calcitriol group (P <0.05), and those with the x allele had a significantly greater decrease in serum cholesterol in the hormone therapy + calcitriol group at the end of 3 years versus the X allele, and a greater decrease in serum LDL in alleles x versus the X in the ET + calcitriol group (P <0.05). Conclusions: ET with or without progesterone had a favorable effect on lipid profile in postmenopausal older women, and this was dependent on estrogen receptor SNPs-PvuII and XbaI. However, this interaction with ESR-α SNPs needs to be confirmed in larger studies.
AB - Objective: The aim of this study was to examine the effect of conjugated equine estrogens alone (ET), conjugated equine estrogens + medroxyprogesterone (EPT), calcitriol alone, calcitriol + EPT/ET, or placebo on serum lipid profile and analyze the interaction with estrogen receptor-α gene single nucleotide polymorphisms (ESR-α SNPs) on the response to therapy. Methods: A total of 489 postmenopausal women older than 65 years were enrolled into a 3-year double-blind, placebo-controlled clinical trial. Results: In both intent-to-treat and complier (>80% adherent) analysis, there was a significant increase in serum high-density lipoproteins and a significant decrease in serum low-density lipoproteins (LDLs) and the LDL/high-density lipoprotein ratio in all hormone treatment groups compared with placebo (P <0.05). However, serum triglycerides and very low-density lipoproteins increased in the EPT and ET + calcitriol groups versus placebo (P <0.05). ESR-α SNPs PvuII and XbaI seemed to have a significant effect on the response to treatment. Genotypes containing the p allele showed a significantly greater decrease in serum cholesterol and very low-density lipoprotein than those having the P allele in the ET + calcitriol group (P <0.05), and those with the x allele had a significantly greater decrease in serum cholesterol in the hormone therapy + calcitriol group at the end of 3 years versus the X allele, and a greater decrease in serum LDL in alleles x versus the X in the ET + calcitriol group (P <0.05). Conclusions: ET with or without progesterone had a favorable effect on lipid profile in postmenopausal older women, and this was dependent on estrogen receptor SNPs-PvuII and XbaI. However, this interaction with ESR-α SNPs needs to be confirmed in larger studies.
UR - http://www.scopus.com/inward/record.url?scp=80053263600&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053263600&partnerID=8YFLogxK
U2 - 10.1097/gme.0b013e318217d41d
DO - 10.1097/gme.0b013e318217d41d
M3 - Article
C2 - 21712736
AN - SCOPUS:80053263600
VL - 18
SP - 1101
EP - 1112
JO - Menopause
JF - Menopause
SN - 1072-3714
IS - 10
ER -